沈阳体癣治疗选择哪家医院好沈阳哪家治疗过敏性皮炎,沈阳青春痘要用多少钱,沈阳治痘痘一共要多少钱,沈阳胳肢窝狐臭去除得花多少钱,看痘痘粉刺沈阳哪家医院好,沈阳看风疹块比较专业的医院,脂溢性脱发沈阳哪家医院好

The U.S. Constitution states in order to be president, you must be 35 years of age, a natural born citizen, and must have lived in the United States for at least 14 years. To become vice president, you have to be eligible to become president.Sen. Kamala Harris, 55, was born in Oakland, California, in 1964 and a US citizen at birth. Akin to the controversy he tried to stir during the Barack Obama's Presidency, President Donald Trump suggested on Thursday that Harris isn’t eligible to run for vice president.Harris on Tuesday was announced as Joe Biden’s running mate on this year’s Democratic presidential ticket."I heard it today that she doesn't meet the requirements. And, by the way, the lawyer that wrote that piece is a very qualified, very talented lawyer,” Trump said.On Thursday, Newsweek published an op-ed questioning her eligibility. Newsweek defended the op-ed's publication. The argument that the op-ed makes, penned by John C. Eastman, is that Harris isn't a natural born citizen because her parents were not US citizens at the time of her birth. The issue Eastman raises is that the US constitution does not define "natural born citizen." But the 14th amendment clearly states that those born on US soil are citizens at birth."All persons born or naturalized in the United States, and subject to the jurisdiction thereof, are citizens of the United States and of the state wherein they reside," the amendment reads.Similar controversies have transpired when Sens. John McCain and Ted Cruz ran for president. Both were US citizens at birth, but were not born on US soil. Harris was born to two immigrant parents, a Jamaican father and Indian mother. According to his official college biography, Harris’ father Donald J. Harris was born a Jamaican citizen but has naturalized as an American citizen. Donald J. Harris is a professor emeritus at Stanford.According to her official obituary, the senator’s mother Shyamala Gopalan Harris, who died in 2009, came to the United States as a teenager and began participating in the Civil Rights Movement. She then became a cancer researcher at UC Berkeley. 2124

The woman had used oxycodone for almost a decade but told her doctors she had been sober for two years. She never touched narcotics during her pregnancy, she said, and had completed rehab.But her newborn son was in withdrawal: jittery, screaming and requiring an infusion of morphine to stay alive. The infant craved drugs, but why?Amid an opioid epidemic, the boy's doctors didn't blame heroin, fentanyl or other illicit substances. Instead, they said, the infant had grown dependent on a controversial herbal supplement: kratom. 538

The Trump administration asked the Supreme Court on Monday to take up a case concerning the government's decision to phase out an Obama-era initiative that protects from deportation young undocumented immigrants who came to the United States as children.In doing so, government lawyers sought to bypass federal appeals courts that have yet to rule definitively on the Deferred Action for Childhood Arrivals program.In court papers, Solicitor General Noel Francisco asked the justices to take up the case this term and argued that district judges who had issued opinions against the administration were "wrong" to do so. Francisco pointed out that back in 2012 the Obama administration allowed some "700,000 aliens to remain in the United States even though existing laws provided them no ability to do so."Francisco said that "after a change in administrations" the Department of Homeland Security ended the policy "based on serious doubts about its legality and the practical implications of maintaining it."The filing came the night before the midterm elections as President Donald Trump has repeatedly brought up immigration to rally his base in the final hours before the vote.In September 2017, the government announced plans to phase out the program, but lower court judges blocked the administration from doing so and ordered that renewals of protections for recipients continue until the appeals are resolved.The legality of the program is not at issue in the case. Instead, lower courts are examining how the government chose to wind it down.Supporters of the roughly 700,000 young immigrants who could be affected by the end of DACA say the administration's actions were arbitrary and in violation of federal law. 1736

The US Food and Drug Administration pressed forward with its investigation of e-cigarette companies Friday, sending letters to 21 companies in an effort to uncover whether they are marketing products illegally and outside the agency's compliance policy.This latest phase of the investigation addresses more than 40 e-cigarette products and is part of the agency's ongoing efforts to combat e-cigarette use among youth. It also comes less than two weeks after the agency conducted a surprise inspection of e-cigarette maker Juul's corporate headquarters in San Francisco, seizing thousand of documents, many of which relate to its sales and marketing practices."Companies are on notice," FDA Commissioner Dr. Scott Gottlieb said in a statement Friday. "The FDA will not allow the proliferation of e-cigarettes or other tobacco products potentially being marketed illegally and outside of the agency's compliance policy, and we will take swift action when companies are skirting the law."In September, Gottlieb called the increasing teen use of e-cigarettes "an epidemic," adding that teen nicotine use is dangerous to young people's health and brains.Federal law prohibits the sale of e-cigarettes to people under the age of 18, but more than 2 million middle and high school students were current users of e-cigarettes in 2017, according to the FDA. The US Centers for Disease Control and Prevention says it's the most common nicotine product used by middle and high schoolers.Also last month, the FDA requested that five major e-cigarette manufacturers, including Juul, explain how they plan to combat the use of their products by minors. The agency said it was looking into steps to eliminate the sale of flavored products and unveiled a public education campaignabout e-cigarettes.The FDA said it's considering civil and criminal avenues to enforce these regulations, including fines, seizures and injunctions, according to Friday's announcement.CNN reached out to some of the companies that received letters for comment but did not immediately receive a response."We're going to address issues related to the access kids have to e-cigarettes, as well as the youth appeal of these products," Gottlieb said Friday. "We know flavors are one of the principal drivers of the youth appeal of e-cigarettes and we're looking carefully at this."No reasonable person wants to see these products reaching epidemic use among kids," he said. 2500

The US Food and Drug Administration expanded?the list of drugs being recalled that contain valsartan. The drug is used as a component in a set of drugs used to treat heart failure and blood pressure.New to the list are some valsartan products manufactured by Hetero Labs Ltd. in India, which are labeled as Camber Pharmaceuticals Inc. Test results show that some of the products may be tainted.The FDA announced a valsartan recall in July after lab tests revealed that some drugs could have been tainted with a substance linked to higher risk of cancer. The drug had been recalled in 22 other countries. The expanded recall includes some drugs that contain valsartan and hydrochlorothisazide. Not all of the drugs containing valsartan were affected.N-nitrosodimethylamine or NDMA, the impurity the lab tests found, is considered a?possible carcinogen by the US Environmental Protection Agency. It is an organic chemical that has been used to make liquid rocket fuel, and it can be unintentionally introduced through certain chemical reactions. It's a byproduct of the manufacturing of some pesticides and fish processing.The medicines that are now a part of this expanded list?in the recall are tablets sold by AvKare, A-S Medication Solutions LLC, Bryant Ranch Prepack Inc, Camber Pharmaceuticals, Inc. H J Harkins Company, Northwind Pharmaceuticals, NuCare Pharmaceuticals Inc., Prinston Pharmaceutical Inc. (labeled as Solco Healthcare LLC), Proficient Rx LP, Remedy Repack, Teva Pharmaceuticals (labeled as Major Pharmaceuticals), Teva Pharmaceuticals USA (labeled as Actavis).The FDA also published a list of valsartan products that are not currently recalled. Only the drugs suspected of being tainted with NDMA are on the recall list. If you are taking a valsartan drug, look for the company name on your prescription bottle. If the information isn't on the label, you can call your pharmacy for those details.The recalled medicine is linked to a manufacturer in China. The substances were supplied by Zhejiang Huahai Pharmaceuticals, based in Linhai, in eastern China, which said it notified authorities as soon as it identified the impurity."We published our recall notice at midday on July 13 in China and overseas, and published the US market recall notice on July 14 Beijing time ... all the drug materials for the Chinese market were recalled by July 23," the company said in a statement to the Shanghai stock exchange last month.The FDA said on its website that it's working with drug manufacturers "to ensure future valsartan active pharmaceutical ingredients are not at risk."If you are worried that your drug could be on the recall list, talk with your doctor or pharmacist before changing any routine with your medicine. Because not all valsartan drugs are involved in the recall, they might be able to switch you to a version of the drug made by another company.If you know your drug is on the recall list, the FDA suggests you continue taking it until your doctor or pharmacist provides a replacement.To get a sense of what taking a tainted drug could mean, FDA scientists estimated that if 8,000 people took the highest dose of valsartan (320 milligrams) from the recalled batches every day for four years, there may be one additional case of cancer."The key with this is, patients should not stop taking their medication abruptly, that definitely can be harmful," Dr. Mary Ann Bauman, a representative for the American Heart Association, said in July. "You don't want to jump to any conclusions on your own about this medication, or any medication for that matter. Definitely talk with your doctor first." 3690